SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-352727
Filing Date
2021-12-09
Accepted
2021-12-09 16:40:55
Documents
12
Period of Report
2021-12-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d250286d8k.htm   iXBRL 8-K 24609
  Complete submission text file 0001193125-21-352727.txt   150487

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA inab-20211201.xsd EX-101.SCH 2874
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE inab-20211201_lab.xml EX-101.LAB 18888
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inab-20211201_pre.xml EX-101.PRE 11848
5 EXTRACTED XBRL INSTANCE DOCUMENT d250286d8k_htm.xml XML 3449
Mailing Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118
Business Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118 (646) 600-6438
IN8BIO, INC. (Filer) CIK: 0001740279 (see all company filings)

IRS No.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39692 | Film No.: 211482442
SIC: 2836 Biological Products, (No Diagnostic Substances)